These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6962442)

  • 1. Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors.
    Helmeste DM; Seeman P
    Psychiatry Res; 1982 Dec; 7(3):351-9. PubMed ID: 6962442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
    Helmeste DM
    Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral decortication reverses the effect of amphetamine on striatal D2 dopamine binding site density.
    Robertson HA
    Neurosci Lett; 1986 Dec; 72(3):325-9. PubMed ID: 2950342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lavender oil on motor function and dopamine receptor expression in the olfactory bulb of mice.
    Kim Y; Kim M; Kim H; Kim K
    J Ethnopharmacol; 2009 Aug; 125(1):31-5. PubMed ID: 19560529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine.
    Gianutsos G; Moore KE
    Life Sci; 1977 May; 20(9):1585-91. PubMed ID: 875633
    [No Abstract]   [Full Text] [Related]  

  • 11. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
    Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
    Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors in the striatum and limbic system of various strains of mice: relation to differences in responses to apomorphine.
    Michaluk J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Sansone M; Oliverio A; Vetulani J
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1115-8. PubMed ID: 6891791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of nicotine on the striatal dopaminergic system in the rat.
    Fung YK; Lau YS
    J Pharm Pharmacol; 1986 Dec; 38(12):920-2. PubMed ID: 2880968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA; Finch CE
    Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine induces hypermotility in MPTP-lesioned mice.
    Schroeder U; Kreutz MR; Schroeder H; Sabel BA
    Pharmacol Biochem Behav; 1997 Feb; 56(2):281-5. PubMed ID: 9050086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.